Pär Josefsson

720 total citations
18 papers, 369 citations indexed

About

Pär Josefsson is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Pär Josefsson has authored 18 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 11 papers in Genetics and 6 papers in Oncology. Recurrent topics in Pär Josefsson's work include Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (11 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Pär Josefsson is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (11 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Pär Josefsson collaborates with scholars based in Denmark, Sweden and United States. Pär Josefsson's co-authors include Jesper Jurlander, Judit Jørgensen, Peter de Nully Brown, Christian H. Geisler, Jørgen Holm Petersen, Tarec Christoffer El‐Galaly, Paw Jensen, Anne Mette Buhl, Henrik Leffers and Mette Klarskov Andersen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Pär Josefsson

16 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pär Josefsson Denmark 10 252 179 124 109 44 18 369
Aziz Benzohra United Kingdom 3 296 1.2× 214 1.2× 178 1.4× 66 0.6× 38 0.9× 4 378
Jordan A. Herst Canada 7 263 1.0× 178 1.0× 201 1.6× 33 0.3× 54 1.2× 12 401
Gianpaolo Marcacci Italy 8 192 0.8× 129 0.7× 115 0.9× 60 0.6× 32 0.7× 17 313
Annalisa Gabriele Italy 8 255 1.0× 88 0.5× 112 0.9× 39 0.4× 58 1.3× 12 315
Ulrich von Gruenhagen Germany 10 421 1.7× 289 1.6× 266 2.1× 45 0.4× 54 1.2× 11 458
Emanuela Merla Italy 11 297 1.2× 108 0.6× 143 1.2× 31 0.3× 44 1.0× 17 390
Florence Broussais‐Guillaumot France 9 228 0.9× 95 0.5× 153 1.2× 55 0.5× 24 0.5× 14 305
Steven Corso United States 4 288 1.1× 165 0.9× 216 1.7× 66 0.6× 46 1.0× 9 421
C. Foussard France 12 375 1.5× 236 1.3× 263 2.1× 63 0.6× 22 0.5× 25 517
Greg Hapgood Australia 9 226 0.9× 38 0.2× 123 1.0× 55 0.5× 36 0.8× 28 390

Countries citing papers authored by Pär Josefsson

Since Specialization
Citations

This map shows the geographic impact of Pär Josefsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pär Josefsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pär Josefsson more than expected).

Fields of papers citing papers by Pär Josefsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pär Josefsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pär Josefsson. The network helps show where Pär Josefsson may publish in the future.

Co-authorship network of co-authors of Pär Josefsson

This figure shows the co-authorship network connecting the top 25 collaborators of Pär Josefsson. A scholar is included among the top collaborators of Pär Josefsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pär Josefsson. Pär Josefsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jensen, Paw, Peter de Nully Brown, Pär Josefsson, et al.. (2025). Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real‐World Setting. European Journal Of Haematology. 114(5). 832–839.
2.
Jakobsen, Lasse Hjort, Kristian Kragholm, René Ernst Nielsen, et al.. (2022). Mental health among patients with non‐Hodgkin lymphoma: A Danish nationwide study of psychotropic drug use in 8750 patients and 43 750 matched comparators. American Journal of Hematology. 97(6). 749–761. 14 indexed citations
3.
Clausen, Michael Roost, Sinna Pilgaard Ulrichsen, Maja Bech Juul, et al.. (2020). Prognostic significance of infectious episodes occurring during first‐line therapy for diffuse large B‐cell lymphoma ‐ A nationwide cohort study. Hematological Oncology. 38(3). 318–325. 3 indexed citations
4.
Eskelund, Christian Winther, Konstantinos Dimopoulos, Arne Kolstad, et al.. (2020). Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3. HemaSphere. 5(1). e510–e510. 17 indexed citations
5.
Bæch, Joachim, Lasse Hjort Jakobsen, Marianne Tang Severinsen, et al.. (2020). Increased risk of osteoporosis following commonly used first-line treatments for lymphoma: a Danish Nationwide Cohort Study. Leukemia & lymphoma. 61(6). 1345–1354. 14 indexed citations
6.
Madsen, Charlotte Bernhard, Trine Lindhardt Plesner, Hans Bentzen, et al.. (2020). Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort. Leukemia & lymphoma. 61(11). 2584–2594. 11 indexed citations
7.
Clausen, Michael Roost, Sinna Pilgaard Ulrichsen, Thomas Stauffer Larsen, et al.. (2019). Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma – a nationwide population-based cohort study. Leukemia & lymphoma. 60(8). 1950–1957.
8.
Bæch, Joachim, Steen Møller Hansen, Peter de Nully Brown, et al.. (2018). Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines. British Journal of Haematology. 183(5). 717–726. 44 indexed citations
9.
Brown, Peter de Nully, Paw Jensen, Judit Jørgensen, et al.. (2017). Malignt Lymfom og CLL: National årsrapport 2016. 1 indexed citations
10.
Jakobsen, Lasse Hjort, Martin Bøgsted, Peter de Nully Brown, et al.. (2017). Minimal Loss of Lifetime for Patients With Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study. Journal of Clinical Oncology. 35(7). 778–784. 63 indexed citations
11.
Arboe, Bente, Pär Josefsson, Christian Poulsen, et al.. (2016). Rituximab Maintenance after First Line Immunochemotherapy Improves Overall Survival in Patients with Follicular Lymphoma. Blood. 128(22). 1781–1781. 2 indexed citations
12.
Arboe, Bente, Pär Josefsson, Judit Jørgensen, et al.. (2016). Danish National Lymphoma Registry. Clinical Epidemiology. Volume 8. 577–581. 47 indexed citations
13.
Buhl, Anne Mette, Pär Josefsson, Christian H. Geisler, et al.. (2013). prediction in chronic lymphocytic leukemia CLLU1 expression analysis adds prognostic information to risk. 1 indexed citations
14.
Darzentas, Nikos, Anastasia Hadzidimitriou, Fiona Murray, et al.. (2009). A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia. 24(1). 125–132. 85 indexed citations
15.
Josefsson, Pär, Christian H. Geisler, Henrik Leffers, et al.. (2007). CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia. Blood. 109(11). 4973–4979. 39 indexed citations
16.
Buhl, Anne Mette, Jesper Jurlander, Christian H. Geisler, et al.. (2006). CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia. European Journal Of Haematology. 76(6). 455–464. 25 indexed citations
17.
Josefsson, Pär, Jesper Jurlander, Christian H. Geisler, et al.. (2005). Validation of the Prognostic Significance of the Disease Specific Gene CLLU1 in Chronic Lymphocytic Leukemia.. Blood. 106(11). 709–709. 2 indexed citations
18.
Buhl, Anne Mette, Jesper Jurlander, Lone Bredo Pedersen, et al.. (2004). A Novel and Disease Specific Gene in Chronic Lymphocytic Leukemia.. Blood. 104(11). 770–770. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aziz Benzohra Breakdown of academic impact, for papers by Jordan A. Herst Breakdown of academic impact, for papers by Gianpaolo Marcacci Breakdown of academic impact, for papers by Annalisa Gabriele Breakdown of academic impact, for papers by Ulrich von Gruenhagen Breakdown of academic impact, for papers by Emanuela Merla Breakdown of academic impact, for papers by Florence Broussais‐Guillaumot Breakdown of academic impact, for papers by Steven Corso Breakdown of academic impact, for papers by C. Foussard Breakdown of academic impact, for papers by Greg Hapgood
Rankless by CCL
2026